Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-24FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for KALYDECO (ivacaftor) from Vertex Pharmaceuticals Incorporated.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Comparison of Absorption of Vitamin D in Cystic Fibrosis [Phase 4]
A Phase 4 trial completed comparing absorption of Vitamin D in individuals with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis
This entry notes a completed clinical trial evaluating sensations of breathlessness in cystic fibrosis patients. No results are provided in …
-
CLINICAL_TRIALS research · 2015-11-09Clinical Trial Update: The Short-term Effect of ELTGOL on Pulmonary Ventilation Valued Through Electrical Impedance Tomography in Cystic Fibrosis Patients [NA]
A clinical trial update evaluating the short-term effect of ELTGOL on pulmonary ventilation in cystic fibrosis patients, assessed by electri…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies
Completed clinical trial comparing microbiological resistance and effects when alternating inhaled antibiotic therapies in cystic fibrosis p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Ext. Long-term Safety Study in CF Patients: Single Arm TIP [Phase 4]
A Phase 4 long-term safety study of TIP in cystic fibrosis patients has been completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642) [Phase 3]
Open-label extension of a Phase 3 study of denufosol tetrasodium inhalation solution in cystic fibrosis has been terminated.
-
CLINICAL_TRIALS research · 2015-11-05Clinical Trial Update: First Study of Oral Cysteamine in Cystic Fibrosis [Phase 1, Phase 2]
The University of Aberdeen conducted a Phase 1/2 clinical trial to evaluate oral cysteamine in individuals with cystic fibrosis, and the stu…
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease [Phase 3]
This Phase 3 clinical trial update reports that denufosol inhalation solution for mild cystic fibrosis lung disease has completed, sponsored…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease [Phase 3]
Phase 3 study of Denufosol Tetrasodium Inhalation Solution in cystic fibrosis patients has completed.
-
CLINICAL_TRIALS research · 2015-10-29Clinical Trial Update: Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation [NA]
This clinical trial update examines upper and lower airway colonization in cystic fibrosis patients after lung transplantation, with attenti…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People [Phase 4]
Phase 4 clinical trial evaluating prolonging the duration of peripheral venous catheters in people with cystic fibrosis; the study was termi…
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Repeated Application of Gene Therapy in CF Patients [Phase 2]
Phase 2 clinical trial update reporting the completion of a study evaluating repeated administration of a gene therapy in cystic fibrosis pa…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Omega 3 Supplementation in Cystic Fibrosis Patients [Phase 3]
Phase 3 trial evaluating omega-3 fatty acid supplementation in patients with cystic fibrosis has completed.
-
CLINICAL_TRIALS withdrawal · 2015-10-21Clinical Trial Update: Zoledronic Acid in Cystic Fibrosis [Phase 4]
A Phase 4 clinical trial evaluating zoledronic acid for cystic fibrosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease [Phase 2]
Phase 2 trial update of denufosol tetrasodium for cystic fibrosis lung disease; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years [Phase 2]
Phase 2 crossover trial completed to assess whether dry powder mannitol improves lung function in children and adolescents with cystic fibro…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Cough-Generated Aerosols of NTM in Cystic Fibrosis
This completed clinical trial examined cough-generated aerosols containing non-tuberculous mycobacteria in people with cystic fibrosis.
-
FDA approval · 2015-10-05FDA Approved: TOBI — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for TOBI (tobramycin) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation [Phase 2]
Phase 2 study evaluating lumacaftor alone and in combination with ivacaftor in cystic fibrosis patients with the F508del-CFTR mutation; resu…
-
FDA approval · 2015-10-02FDA Approved: TOBI PODHALER — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for TOBI PODHALER (tobramycin) from Viatris Specialty LLC. The action relates to the continued use o…
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: Pharmacokinetics of Piperacillin, Given as Continuous Infusion to Patients With Cystic Fibrosis
The trial evaluated the pharmacokinetics of piperacillin given as a continuous infusion in patients with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Improvement of Aerobic Capacity in Cystic Fibrosis Patients With a One-year Home Training Period [NA]
A completed clinical trial found that a one-year home-based training program improved aerobic capacity in cystic fibrosis patients.
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Induction of Neutrophilic Traps ( NETs ) by the Environment and Infectious Inflammatory Lung Cystic Fibrosis
This update reports on a completed clinical trial investigating how environmental and infectious factors drive neutrophil extracellular trap…
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: The Effects of Massage Therapy on QOL in Youth/Young Adults With Cystic Fibrosis [NA]
Completed clinical trial evaluating the effects of massage therapy on quality of life in youth and young adults with cystic fibrosis.